Echo Therapeutics Schedules Third Quarter 2013 Financial Results for Thursday, November 7, 2013

Echo Therapeutics Schedules Third Quarter 2013 Financial Results for Thursday,
                               November 7, 2013

Conference Call to begin at 9:00 a.m. ET

PR Newswire

PHILADELPHIA, Nov. 1, 2013

PHILADELPHIA, Nov.1, 2013 /PRNewswire/ --Echo Therapeutics, Inc. (Nasdaq:
ECTE), a medical device company developing its Symphony^® CGM System as a
non-invasive, wireless continuous glucose monitoring system, today announced
that it will release third quarter 2013 financial results on Thursday,
November 7, 2013. Management will hold a conference call to review the
company's third quarter 2013 performance starting at 9:00 a.m. ET on the same
day.

The dial-in number is (877) 300-8521 and reference Echo Therapeutics 3^rd
Quarter 2013 Earnings Call. The archived audiocast will be available for
fourteen days following the call by visiting the Events section of Echo's
website at www.echotx.com.

About Echo Therapeutics

Echo Therapeutics is developing the Symphony CGM System as a non-invasive,
wireless, continuous glucose monitoring system for use initially in the
critical care setting.Significant opportunity also exists for Symphony to be
used in the hospital beyond the critical care setting, as well as in patients
with diabetes in the outpatient setting.Echo is also developing its
needle-free skin preparation component of Symphony, the Prelude^® SkinPrep
System, as a platform technology to enhance delivery of topical
pharmaceuticals.

For More Information:
Christine H. Olimpio
Director, Investor Relations and Corporate Communications
(215) 717-4104
colimpio@echotx.com

Connect With Us:
- Visit our website at www.echotx.com
- Follow us on Twitter at www.twitter.com/echotx
- Join us on Facebook at www.facebook.com/echotx

SOURCE Echo Therapeutics, Inc.

Website: http://www.echotx.com
 
Press spacebar to pause and continue. Press esc to stop.